Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:Any - 17
Updated:12/1/2016
Start Date:October 2012
End Date:June 2016

Use our guide to learn which trials are right for you!

A 24-month, Multi-center, Single Arm, Prospective Study to Evaluate Renal Function, Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

This study is designed to assess the evolution of renal function and to collect efficacy,
safety, and tolerability data of everolimus in co-exposure with reduced CNI in paediatric
liver transplant recipients.

Study is active and ongoing but no longer recruiting since December 2014. The study Data
Monitoring Committee meeting communicated to Novartis safety findings in the group of
children younger than 7 years of age: high rate of premature discontinuation of study
medication, high rate of post-transplant lymphoproliferative disease and high rate of
related serious infections leading to hospitalization. In light of the safety findings,
Novartis followed the DMC recommendation to discontinue the study medication in this age
group and to stop enrolling new patients in this study (regardless of age).

Key Inclusion Criteria:

Signed informed consent from both parents or legal guardian(s) prior to patient
participation in the study.

Paediatric liver transplant recipients aged greater than or equal to 1 month and younger
than 18 years of age.

Paediatric recipients at the earliest 1 month and latest 6 month after liver
transplantation.

Key Exclusion Criteria:

Patients with hepato-biliary malignancies and/or patients transplanted due to fulminant
hepatitis /acute liver failure.

Presence of thrombosis of any major hepatic arteries, major/reconstructed hepatic veins,
portal vein or inferior vena cava at any time prior to the start of study drug.

Patients with serum creatinine value >2 times age-related ULN at Baseline or who received
renal replacement therapy within one week prior to the start of study drug and patients
with a confirmed spot urine protein/creatinine ratio indicating a urinary protein
excretion >500 mg/m2/24 hrs, at Baseline.

Patients with clinically significant systemic infection and/or in a critical care setting
requiring life support measures such as mechanical ventilation, dialysis, or vasopressor
agents.

Patients with a known hypersensitivity to the drugs used on study or their class, or to
any of the excipients.

Pregnant or nursing (lactating) female patients, where pregnancy is defined as the state
of a female after conception and until the termination of gestation, confirmed by a
positive βHCG laboratory test (>9 mIU/mL) at Baseline.

Female patients of child-bearing potential, defined as all women physiologically capable
of becoming pregnant, UNLESS they agree for abstinence from sexual activity.
We found this trial at
12
sites
Charleston, South Carolina 29407
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90095
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90095
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Madison, Wisconsin 53705
?
mi
from
Madison, WI
Click here to add this to my saved trials
New Haven, Connecticut
?
mi
from
New Haven, CT
Click here to add this to my saved trials
230 Park Avenue, 21st Floor
New York, New York 10169
1-888-669-6682)
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
?
mi
from
New York, NY
Click here to add this to my saved trials
Parkville, Victoria
?
mi
from
Parkville,
Click here to add this to my saved trials
Salt Lake City, Utah 84103
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
St Louis, Missouri 63104
?
mi
from
St Louis, MO
Click here to add this to my saved trials